Commonwealth of Pennsylvania

01/30/2026 | Press release | Distributed by Public on 01/30/2026 12:18

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

January 30, 2026- Allentown, PA

Governor Shapiro Secures Historic $3.5 Billion Investment from Lilly to Build New, State-of-the-Art Pharmaceutical Manufacturing Facility in Lehigh County, Creating 850 New Jobs

Governor Josh Shapiro and Pennsylvania Department of Community & Economic Development (DCED) Secretary Rick Siger announced the Commonwealth has secured a $3.5 billion private-sector investment from global pharmaceutical firm Eli Lilly and Company to build a new, state-of-the-art pharmaceutical manufacturing facility in Lehigh County. Lilly's investment is the largest by a life sciences company in Commonwealth history.

Supported by $100 million in Commonwealth investment, this expansion project will create at least 850 new jobs over the next five years and continue growing Pennsylvania's robust pharmaceutical and life sciences industries.

Lilly is purchasing a site in Fogelsville. This will be the first Lilly manufacturing facility in Pennsylvania and represents a long-term commitment to the Commonwealth from one of the world's leading drugmakers.


List of Speakers:
David A. Ricks, Lilly chair and CEO
Governor Josh Shapiro
Don Cunningham, President and CEO, Lehigh Valley Economic Development Corp
County Executive Josh Siegel, Lehigh County
Jeff Fleischaker, Chair, Upper Macungie Township Board of Supervisors
Paul Anthony, President, Lehigh Valley Building Trades






Commonwealth of Pennsylvania published this content on January 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 30, 2026 at 18:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]